top of page
TransHeps
Serving global Pharma Drug Developers and Regulators by providing the MetaHeps assay as a decision-enabling drug development tool for DILI causality assessment in clinical studies
Using the power of the MetaHeps assay
The leadership team
Prof. Armin Wolf, PhD
CEO and Founder
Martin Birk, 3xMSc
CFO/COO and Founder
Michele Visentin, PhD
VP Science and
Co-Founder
Sophia Samodelov, PhD
VP Business and
Co-Founder
Contact Us
Get in touch to find out more about our TransHeps technology
Address
Lab address:
TransHeps AG (BIO-TECHNOPARK)
Room 101-104
Wagistrasse 14, 8952 Schlieren, Zurich, Switzerland
Legal address:
TransHeps AG
Kirchstrasse 1, 8104 Weiningen, Zurich, Switzerland
Social Media
bottom of page